NGI-1 (ML414) (Synonyms: N-linked Glycosylation Inhibitor 1) |
| Catalog No.GC33055 |
NGI-1 (ML414) (ML414) est un puissant inhibiteur de l'oligosaccharyltransférase (OST), ciblant et bloquant directement la fonction des sous-unités catalytiques OST STT3A et STT3B. NGI-1 (ML414) est un inhibiteur perméable aux cellules et peut réduire efficacement l'infectivité virale sans affecter la viabilité cellulaire.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 790702-57-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
NGI-1 is a cell permeable inhibitor.
NGI-1 blocks EGFR N-linked glycosylation in lung adenocarcinoma cells as assessed. In controls EGFR is biotinylated, consistent with its plasma membrane expression, but in NGI-1 treated cells the EGFR is predominantly found in the non-biotinylated intracellular fraction suggesting a change in cellular localization[1].
[1]. Lopez-Sambrooks C, et al. Oligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells. Nat Chem Biol. 2016 Dec;12(12):1023-1030.
Average Rating: 5 (Based on Reviews and 7 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *